Treatment interruptions in patients with prolonged immunologic and virologic responses to highly active antiretroviral therapy (HAART) have been advocated in many circles, especially if the CD4+ count ...
The drug had minimal effect on the low CD4-cell counts of immunologic nonresponders. Most HIV-infected patients with adequate virologic suppression on antiretroviral therapy (ART) will eventually ...
HIV positive patients who take combination antiretroviral therapy (cART) to combat HIV infection could see the numbers of CD4 cells in their immune system rise to concentrations found in HIV negative ...
People who are HIV positive, but whose level of the virus in their body is so low that blood tests can’t detect it, are not at significantly higher risk of contracting coronavirus, according to an HIV ...
AIDS drug cocktails may be able to restore the ravaged immune systems of some people infected with HIV, researchers reported on Wednesday. Immune cells known as CD4 T-cells returned to normal levels ...
HIV-1-infected U.S. military members and beneficiaries treated with antiretroviral therapy (ART) soon after infection were half as likely to develop AIDS and were more likely to reconstitute their ...
For HIV-infected patients whose disease is well-controlled by modern treatment, the risk of death is not significantly higher than in the general population, according to a new study. Philadelphia, Pa ...
Daniel R. Lucey, Stephen A. McGuire, Mario Clerici, Kevin Hall, Jean Benton, Clifford A. Butzin, William W. Ward, Gene Shearer, R. Neal Boswell and Craig W. Hendrix β₂-microglobulin levels were ...
The pathway causing CD4 T-cell death in HIV-infected hosts remains poorly understood although apoptosis has been proposed as a key mechanism. We now show that caspase-3-mediated apoptosis accounts for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results